FDA approves first drug to treat hallucinations and delusions associated with Parkinson’s disease - FDA Press Releases

The U.S. Food and Drug Administration today approved Nuplazid (pimavanserin) tablets, the first drug approved to treat hallucinations and delusions associated with psychosis experienced by some people with Parkinson’s disease.

from FDA Press Releases RSS Feed https://ift.tt/34yO0Mq
via IFTTT